We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$11.4B
AUM Growth
-$318M
Cap. Flow
+$3.49M
Cap. Flow %
0.03%
Top 10 Hldgs %
29.99%
Holding
100
New
2
Increased
15
Reduced
62
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.8M
2
GSK icon
GSK
GSK
+$48.1M
3
TECK icon
Teck Resources
TECK
+$21.6M
4
AVNS
Avanos Medical
AVNS
+$6.39M
5
CVE icon
Cenovus Energy
CVE
+$4.92M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$37M
2
TLM
TALISMAN ENERGY INC
TLM
+$12.4M
3
KMB icon
Kimberly-Clark
KMB
+$10.3M
4
TRI icon
Thomson Reuters
TRI
+$8.19M
5
SLF icon
Sun Life Financial
SLF
+$6.7M

Sector Composition

Rank Sector Weight
1 Financials 22.78%
2 Energy 19.58%
3 Communication Services 12.9%
4 Technology 8.07%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCJ icon
51
Cameco
CCJ
$40.5B
$80.4M 0.7%
4,894,489
-36,275
-0.7% -$622K
JCI icon
52
Johnson Controls International
JCI
$93.1B
$80.1M 0.7%
1,583,032
-13,131
-0.8% -$642K
MRO
53
DELISTED
Marathon Oil Corporation
MRO
$79.7M 0.7%
2,816,581
-7,500
-0.3% -$239K
LPNT
54
DELISTED
LifePoint Health, Inc.
LPNT
$73.4M 0.64%
1,020,295
-47,185
-4% -$3.27M
ERIC icon
55
Ericsson
ERIC
$33.1B
$71.8M 0.63%
5,935,696
-184,500
-3% -$2.22M
MDT icon
56
Medtronic
MDT
$110B
$52M 0.45%
719,680
-3,775
-0.5% -$262K
AXLL
57
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$50.8M 0.44%
1,196,175
-2,825
-0.2% -$115K
GSK icon
58
GSK
GSK
$103B
$46.8M 0.41%
875,570
+859,850
+5,470% +$48.1M
ELP
59
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$45M 0.39%
8,551,645
-38,188
-0.4% -$206K
OVV icon
60
Ovintiv
OVV
$17.1B
$44.7M 0.39%
642,061
-1,975
-0.3% -$168K
FSLR icon
61
First Solar
FSLR
$25B
$37M 0.32%
830,422
-9,625
-1% -$490K
TFC icon
62
Truist Financial
TFC
$63.4B
$37M 0.32%
950,775
+33,775
+4% +$1.27M
PGH
63
DELISTED
Pengrowth Energy Corporation
PGH
$36.6M 0.32%
11,605,850
+19,900
+0.2% +$73.5K
TC
64
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
$30M 0.26%
18,031,424
+150,925
+0.8% +$276K
VWO icon
65
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$29.1M 0.25%
728,000
– –
CHL
66
DELISTED
China Mobile Limited
CHL
$26.6M 0.23%
451,400
-350
-0.1% -$21K
CVX icon
67
Chevron
CVX
$385B
$26.3M 0.23%
234,307
-1,025
-0.4% -$116K
SBS icon
68
Sabesp
SBS
$19.1B
$21.1M 0.18%
17,332,996
-67,808
-0.4% -$96.8K
PDS
69
Precision Drilling
PDS
$996M
$21M 0.18%
172,199
– –
IEMG icon
70
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$20M 0.17%
425,000
– –
SMI
71
DELISTED
Semiconductor Manufacturing Intl
SMI
$19.3M 0.17%
4,269,616
-358,400
-8% -$1.79M
IBN icon
72
ICICI Bank
IBN
$109B
$18.8M 0.16%
1,789,700
– –
INFY icon
73
Infosys
INFY
$51B
$16.4M 0.14%
2,080,000
– –
EEM icon
74
iShares MSCI Emerging Markets ETF
EEM
$29.7B
$16M 0.14%
406,900
– –
IIF
75
Morgan Stanley India Investment Fund
IIF
$219M
$14.4M 0.13%
535,150
– –
1 2
3
4

Similar funds

NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
EIP
Energy Income Partners Westport, Connecticut $6.22B AUM 18.97% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
CA
Cambridge Associates Boston, Massachusetts $6.27B AUM 14.78% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Letko, Brosseau & Associates held 100 positions worth $11.4B, down 2.7% from $11.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 4%. Letko, Brosseau & Associates opened 2 new positions and exited 2, leaving the 100-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Energy and Communication Services.

  • Letko, Brosseau & Associates's largest Q4 2014 buy was Avanos Medical: 162,551 shares worth $7.39M.
  • Letko, Brosseau & Associates added most to Gilead Sciences in Q4 2014, an estimated $61.8M increase.
  • Letko, Brosseau & Associates's biggest Q4 2014 reduction was TALISMAN ENERGY INC, cutting an estimated $12.4M.
  • Letko, Brosseau & Associates fully exited AstraZeneca in Q4 2014, selling an estimated $37M.
  • Letko, Brosseau & Associates's ten largest holdings make up 30% of its $11.4B portfolio in Q4 2014.
  • Letko, Brosseau & Associates opened 2 new positions and closed 2 in Q4 2014.
  • Letko, Brosseau & Associates's portfolio value fell 2.7% quarter-over-quarter to $11.4B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2014, filed 10 Feb 2015.